Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / Fluorescent Imaging DemystifiesMelanoma
Oncology Point of care testing Microscopy and imaging Research and Innovations Molecular Pathology

Fluorescent Imaging Demystifies Melanoma

Study validates non-invasive molecular imaging device for point-of-care assessment of suspicious moles

By Helen Bristow 02/10/2026 Technology 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Top Institutions in Dermatology and Oncologic Imaging

Leading institutions in dermatology and cancer imaging have pioneered the integration of advanced molecular imaging technologies with clinical dermatologic assessment, combining expertise in melanoma biology, imaging technology development, and clinical trials to validate diagnostic accuracy and clinical utility of novel non-invasive tests like SFI.

  • #1

    Memorial Sloan Kettering Cancer Center

    New York, NY

    MSKCC is a global leader in melanoma research and clinical care, with extensive programs in molecular diagnostics and imaging technologies that improve early detection and treatment of skin cancers.

    Key Differentiators

    • Dermatology
    • Oncology
    • Molecular Imaging
  • #2

    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    UCSF has a robust translational research program focused on novel imaging modalities and molecular diagnostics in dermatology, with significant contributions to non-invasive melanoma detection methods.

    Key Differentiators

    • Dermatology
    • Cancer Imaging
    • Translational Research
  • #3

    Johns Hopkins University School of Medicine

    Baltimore, MD

    Johns Hopkins combines expertise in dermatologic oncology with biomedical engineering to innovate molecular imaging technologies and improve melanoma diagnostic accuracy.

    Key Differentiators

    • Dermatology
    • Oncology
    • Biomedical Engineering
  • #4

    Massachusetts General Hospital

    Boston, MA

    MGH integrates dermatology and radiology expertise to advance imaging-based diagnostics for melanoma, supported by strong cancer biology research programs.

    Key Differentiators

    • Dermatology
    • Radiology
    • Cancer Biology
  • #5

    Stanford University Medical Center

    Stanford, CA

    Stanford is recognized for cutting-edge research in molecular imaging and dermatologic oncology, with active development of novel diagnostic technologies for melanoma.

    Key Differentiators

    • Dermatology
    • Molecular Imaging
    • Cancer Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Intense Intestines
Microscopy and imaging
Intense Intestines

January 19, 2024

1 min read

Some powerful fluorescent microscopy in this Image of the Month…

Context Matters in Cancer Biology
Microscopy and imaging
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

When Pathology Goes 3D
Microscopy and imaging
When Pathology Goes 3D

February 2, 2022

1 min read

Stratifying cancers with non-destructive 3D pathology

Sacrificing Safety for Speed?
Microscopy and imaging
Sacrificing Safety for Speed?

February 4, 2022

3 min read

Wide adaptation of antigen testing could increase the risk of exposure to infectious SARS-CoV-2 samples

Affiliations:

Specialties:

Areas of Expertise:

View Full Profile Follow
Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.